JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 46(2012) N 3 p. 362-374;
T.A. Shelkovnikova1,3*, A.A. Kulikova3, P.O. Tsvetkov3, O. Peters2, S.O. Bachurin1, V.L. Buchman2, N.N. Ninkina1,2

Proteinopathies, Neurodegenerative Disorders with Protein Aggregation-Based Pathology

1Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, 142432 Russia
2Cardiff University, Cardiff, CF10 3 US, UK
3Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia

*sta.ipac@gmail.com
Received - 2011-08-21; Accepted - 2011-10-14

A number of neurodegenerative disorders were recently coalesced into a group of proteinopathies based on the similarity of molecular mechanisms underlying their pathogenesis. A key step in the development of proteinopathies is a structural change that triggers aggregation of the proteins that are intrinsically prone to form aggregates owing to their physical and chemical properties. The review considers the recent progress in the field of proteinopathies with a special focus on the properties of aggregation-prone proteins, the main stages of the development of molecular pathology, and the role of cell clearance systems in the progression of neurodegeneration. Recent modifications made to the nomenclature of neurodegenerative diseases on the basis of the molecular mechanism of neurodegeneration are also addressed.

neurodegenerative disorders, proteinopathies, amyloid, synuclein, prions



JMB-FOOTER RAS-JOURNALS